Kanami Abe1, Munenari Itoh1, Akihiko Asahina1. Show Affiliations » 1. Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.
Abstract
Entities: Chemical Disease
Mesh： See more » Antigen-Antibody Complex/immunologyAntigens, CD20/immunologyAntigens, CD20/metabolismAntineoplastic Agents, Immunological/adverse effectsAntineoplastic Agents, Immunological/pharmacologyBiopsyDermis/pathologyHumansLymphoma, Follicular/drug therapyLymphoma, Follicular/immunologyMaleMiddle AgedRituximab/adverse effectsRituximab/pharmacologyVasculitis, Leukocytoclastic, Cutaneous/chemically inducedVasculitis, Leukocytoclastic, Cutaneous/immunologyVasculitis, Leukocytoclastic, Cutaneous/pathology
Substances： See more » Antigen-Antibody ComplexAntigens, CD20Antineoplastic Agents, ImmunologicalRituximab
Year: 2019 PMID： 30969435 DOI： 10.1111/1346-8138.14872
Source DB: PubMed Journal: J Dermatol ISSN： 0385-2407 Impact factor: 4.005